So they're continuing to collect data post the primary completion date, like numerous other major clinical studies. -Would probably be remiss if they didn't.
-"means nothing" in my not so HO on this one.
Bottom Line:Report by end of Q1 2011.
The only thing we might have to wait for, though I don't expect it(in the event of a near miss)is some clarification on the relative OS between cohorts.
Nevertheless, that would have no bearing on the Q1 report of primary completion data.